Member Info for 13thmonkey

Monitoring is where they can't agree on a price, stockopedia will explain better.
Btw we're entitled too opinions too, and we're entitled to react to your opinion, and judge you based on it. Everyone gets to have an opinion even if you don't want them too.
Educate yourself so that people's opinions change for the better.

Same here, love the tech, concerned about the stability of the structure.

You think us few here effect the SP? I've got 23/24 down over the last few days.

Thanks Mike, did you sell before the big rise?

You'll never time the market perfectly, if you are believing it will be a lot higher based on research than just wait, don't begrudge 10p difference in the price. It's might be a pointer to slowly buying in but of course it could have climbed at which point you'd begrudge that.

Do you mean investment, if you do then what's your concern, do you mean trade, if you do then that's your concern.

Gpt, they're generally working on a subscription model, so each sale is small and hence not RNSd. Look at labskin, no announcements, until it was revealed that we had n of the top 10, 5 or 6 perhaps. Every other announcement about other things they are doing well end up in the subscription model for PD or one of the other arms. The results will be in the results not in an RNS in my opinion.

Evans 2 months ago what was foreseen is different to what they were able to understand as time passed. So now they understand that cash would be useful to take advantage of opportunities. I don't think that they anticipated large orders, they want many small orders, that may have led to discussions about additional functionality/capability. I want them to take advantage and if that needs more cash so be it.

How does that help? You understand that the company gets not a penny from you buying or selling on the market.

Statistically there should be no surprises at a lower number given the small sample size so far, nothing will have changed in either the test or the assumptions. It's just the nature of a sample of 30, your answer is either 100%, 96.7%, 93.3%, 90% etc. You increase to a sample of 100 and 99%, 98%, 97% etc become available.

The auction might be a symptom, essentially how I imagine it works is that there are buyers, but no one is willing to sell at anything like the current prices. So they keep on having to raise the price until someone is willing to sell, to meet their demand and refill their buffer. Obviously big news can do this. The auction though is then a symptom where the MMs have to agree what to do next. Sticky hands will help this to happen and happen with a bigger jump.

are you at it again goldtrig? you have a shift of 100 people, for a 10min test you need to pay them all to arrive 10mins early, 1000 man mins of extra pay required 16hrs, for a 30min test you need to pay them all for 30mins. In the first example you might just say sod it and we'll start production 10mins late.
I'm sorry if that's complex to understand.

Businesses paying for an extra 30mins of time Vs less time is beneficial.

Bear in mind the trade credits on ii.

RT that's been my argument of other subscription model shares, most sales (by volume), are small enough to not warrant an RNS and it'll all come out at qrtly updates. Big ones are great to have!

Devon, we often get people with no/little previous posting history suddenly posting 'I'm concerned...' and bringing up a tiny point or weak competitor that's already been considered. So far you are behaving exactly like every other person with a really weak argument who has only popped up to sow doubt. At least make it interesting for us, come up with a point we've not considered and perhaps should have done.

Ah!

But not below 40?

Imagine how different the French lockdowns would be if they could accurately and rapidly test. Could be released in a week.

Romana my point is that 3% dilution is irrelevant in the scheme of things, a share scheme issue could create the same amount. So what's happening here is unrelated to the extra 3% shares issued.